NasdaqGS - Nasdaq Real Time Price
USD
Aardvark Therapeutics, Inc. (AARD)
1.2650
-0.0950
(-6.99%)
As of 11:26:46 AM EST. Market Open.
Trade AARD on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Dr. Tien-Li Lee M.D.
|
CEO, Secretary & Chairman | 973.66k | -- | 1975 |
|
Mr. Nelson B. Sun M.B.A.
|
CFO & COO | 603.3k | -- | 1977 |
|
Dr. Manasi Sinha Jaiman M.D., M.P.H.
|
Chief Medical Officer | 693.04k | -- | 1981 |
|
Dr. Dvorit Samid Ph.D.
|
Executive Vice President of Medical Affairs | -- | -- | -- |
|
Dr. Zhenhuan Zheng Ph.D.
|
Chief Research Officer | -- | -- | -- |
|
Mr. Ron Lewis II, Ph.D.
|
VP & Head of CMC | -- | -- | -- |
|
Mr. Justin T. Stege Ph.D.
|
VP and Head of Project Management & Strategy | -- | -- | -- |
|
Mr. Derrick C. Li
|
Chief Business Officer | -- | -- | -- |
Aardvark Therapeutics, Inc.
4370 La Jolla Village Drive
Suite 1050
San Diego, CA 92122
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 28
Description
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
Corporate Governance
Aardvark Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
November 12, 2026 at 9:00 PM UTC
Aardvark Therapeutics, Inc. Earnings Date
